SCHEMBL4450022

SCHEMBL4450022

O=C(Nc1ccc2c(c1)OCCO2)N[C@H]1[C@@H]2CN(c3ccc(F)cc3F)C[C@@H]21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.54
NPC1 O15118 11/20 0.54
KMT2A Q03164 6/20 0.54
MEN1 O00255 4/20 0.54
SMN1; SMN2 Q16637 6/20 0.50
TP53 P04637 4/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
MAPT P10636 4/20 0.48
POLB P06746 2/20 0.48
TRPV1 Q8NER1 1/20 0.45
HPGD P15428 1/20 0.45
ATM Q13315 1/20 0.45
MAOB P27338 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450024 1.00 RAB9A (0.54) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL13783957 1.00 RAB9A (0.54) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4460386 0.86 MAPT (0.61) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4460394 0.86 MAPT (0.61) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4330504 0.80 MTOR (0.48)
SCHEMBL4454924 0.79 KMT2A (0.39) RAB9ANPC1KMT2AMEN1TP53
SCHEMBL4454929 0.79 KMT2A (0.39) RAB9ANPC1KMT2AMEN1TP53
SCHEMBL13784017 0.79 KMT2A (0.39) RAB9ANPC1KMT2AMEN1TP53
SCHEMBL13783979 0.78 CASP3 (0.43) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4451601 0.78 CASP3 (0.43) RAB9ANPC1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO claimed
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed